GlobalDeal

Akouos

Biotechnology · Boston, United States

akouos.com

About Akouos

Akouos is a biotechnology company focused on developing gene therapies for the treatment of hearing loss and other auditory disorders. Founded in 2016, the company is pioneering the use of its proprietary AAV-based gene therapy platform to deliver therapeutic genes directly to the inner ear. Akouos aims to restore and preserve hearing through innovative treatments that target the underlying causes of hearing loss. The company is committed to advancing its pipeline of product candidates, which includes therapies for both congenital and acquired forms of hearing loss. With a strong emphasis on research and development, Akouos collaborates with leading academic institutions and industry partners to bring its therapies from the lab to the clinic. The company is headquartered in Boston, Massachusetts, and is publicly traded on the NASDAQ under the ticker symbol AKUS.

Company facts

Industry
Biotechnology
Sub-industries
Gene Therapy, Pharmaceuticals, Healthcare, Medical Devices, Regenerative Medicine
Location
Boston, United States
Employees
51–200
Revenue (USD)
<1M
Founded
2016

Products and services

Open Akouos in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →